Research progress on the mechanism of secondary bacterial infection of influenza virus
Secondary bacterial infection of influenza virus
Keywords:
Bacteria, co-infection, influenza virusAbstract
A secondary bacterial infection of the influenza virus in the lungs is a key cause of exacerbation and death. The pathogenesis is characterized by complex interactions between co-infecting pathogens and the host, leading to the destruction of the physical barrier of the airways and the dysregulation of the immune response. This article will review the progress of the mechanism of secondary bacterial infection of influenza virus and provide strategies for preventing the co-infection of influenza virus and bacteria.
References
Robinson KM, Kolls JK, Alcorn JF. The immunology of influenza virus-associated bacterial pneumonia. Curr Opin Immunol 2015;34:59-67.
Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: Implications for pandemic influenza preparedness. J Infect Dis 2008;198:962-70.
Rice TW, Rubinson L, Uyeki TM, Vaughn FL, John BB, Miller RR 3rd, et al. Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit Care Med 2012;40:1487-98.
Shieh WJ, Blau DM, Denison AM, Deleon-Carnes M, Adem P, Bhatnagar J, et al. 2009 pandemic influenza A (H1N1): Pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol 2010;177:166-75.
Randolph AG, Vaughn F, Sullivan R, Rubinson L, Thompson BT, Yoon G, et al. Critically ill children during the 2009-2010 influenza pandemic in the United States. Pediatrics 2011;128:e1450-8.
Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002;359:753-9.
Finelli L, Fiore A, Dhara R, Brammer L, Shay DK, Kamimoto L, et al. Influenza-associated pediatric mortality in the United States: Increase of Staphylococcus aureus coinfection. Pediatrics 2008;122:805-11.
Cauley LS, Vella AT. Why is coinfection with influenza virus and bacteria so difficult to control? Discov Med 2015;19:33-40.
Loosli CG, Stinson SF, Ryan DP, Hertweck MS, Hardy JD, Serebrin R. The destruction of type 2 pneumocytes by airborne influenza PR8-A virus; its effect on surfactant and lecithin content of the pneumonic lesions of mice. Chest 1975;67:7S-14S.
Tianhua W, Kaihu Y. Interaction between influenza virus and Streptococcus pneumonia. Int J Pediatr 2011;38:74-6.
Levandowski RA, Gerrity TR, Garrard CS. Modifications of lung clearance mechanisms by acute influenza A infection. J Lab Clin Med 1985;106:428-32.
McCullers JA, Bartmess KC. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J Infect Dis 2003;187:1000-9.
Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 2000;283:499-505.
Plotkowski MC, Puchelle E, Beck G, Jacquot J, Hannoun C. Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A/PR8 virus. Am Rev Respir Dis 1986;134:1040-4.
Plotkowski MC, Bajolet-Laudinat O, Puchelle E. Cellular and molecular mechanisms of bacterial adhesion to respiratory mucosa. Eur Respir J 1993;6:903-16.
Centers for Disease Control and Prevention (CDC). Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)-United States, May-August 2009. MMWR Morb Mortal Wkly Rep 2009;58:1071-4.
Heilmann C. Adhesion mechanisms of staphylococci. Adv Exp Med Biol 2011;715:105-23.
McCullers JA, Rehg JE. Lethal synergism between influenza virus and Streptococcus pneumoniae: Characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis 2002;186:341-50.
McAuley JL. Chipuk JE, Boyd KL, Van De Velde N, Green DR, McCullers JA. PB1F2 proteins from H5N1 and 20th century pandemic influenza viruses cause immunopathology. PLoS Pathog 2010;6:E1001014.
Alymova IV, Green AM, van de Velde N, McAuley JL, Boyd KL, Ghoneim HE, et al. Immunopathogenic and antibacterial effects of H3N2 influenza A virus PB1F2 map to amino acid residues 62, 75, 79, and 82. J Virol 2011;85:12324-33.
Qiongxuan F, Yan G. Research progress on mixed infection of influenza virus and bacteria. Natl Med J China 2013;93:3724-6.
McCullers JA. Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza. J Infect Dis 2004;190:519-26.
Miller ML, Gao G, Pestina T, Persons D, Tuomanen E. Hypersusceptibility to invasive pneumococcal infection in experimental sickle cell disease involves platelet-activating factor receptor. J Infect Dis 2007;195:581-4.
Martin P, Leibovich SJ. Inflammatory cells during wound repair: The good, the bad and the ugly. Trends Cell Biol 2005;15:599-607.
Puchelle E, Zahm JM, Tournier JM, Coraux C. Airway epithelial repair, regeneration, and remodeling after injury in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006;3:726-33.
Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev 1992;56:152-79.
Chutinimitkul S, van Riel D, Munster VJ, van den Brand JM, Rimmelzwaan GF, Kuiken T, et al.In vitro assessment of attachment pattern and replication efficiency of H5N1 influenza A viruses with altered receptor specificity. J Virol 2010;84:6825-33.
Vigerust DJ, Ulett KB, Boyd KL, Madsen J, Hawgood S, McCullers JA. N-linked glycosylation attenuates H3N2 influenza viruses. J Virol 2007;81:8593-600.
Qingfeng S, Chenyan J, Lufang J. Advances in susceptibility mechanisms of influenza virus-induced secondary pulmonary bacterial infections. Shanghai J Prev Med 2016;28:813-7.
Koppe U, Suttorp N, Opitz B. Recognition of Streptococcus pneumoniae by the innate immune system. Cell Microbiol 2012;14:460-6.
Sun K, Metzger DW. Inhibition of pulmonary antibacterial defense by interferon-γ during recovery from influenza infection. Nature Med 2008;14:558-64.
Ghoneim HE, Thomas PG, McCullers JA. Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections. J Immunol 2013;191:1250-9.
Niemann S, Ehrhardt C, Medina E, Warnking K, Tuchscherr L, Heitmann V, et al. Combined action of influenza virus and Staphylococcus aureus panton-valentine leukocidin provokes severe lung epithelium damage. J Infect Dis 2012;206:1138-48.
Didierlaurent A, Goulding J, Patel S, Snelgrove R, Low L, Bebien M, et al. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J Exp Med 2008;205:323-9.
Downloads
Published
How to Cite
Issue
Section
Downloads
License
Copyright (c) 2020 Liu Lin, Xiangyan Zhang
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
